4//SEC Filing
Appelhans Dannielle 4
Accession 0001104659-23-026139
CIK 0001709401other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:08 PM ET
Size
5.1 KB
Accession
0001104659-23-026139
Insider Transaction Report
Form 4
Appelhans Dannielle
Chief Operating Officer
Transactions
- Sale
Common Stock
2023-02-24$0.13/sh−10,385$1,323→ 0 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1273 to $0.1274, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Rubius Therapeutics, Inc.
CIK 0001709401
Entity typeother
Related Parties
1- filerCIK 0001874962
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 6:08 PM ET
- Size
- 5.1 KB